Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 6, 2013 - Issue
Submit an article Journal homepage
88
Views
2
CrossRef citations to date
0
Altmetric
Review

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia

Fuad El RassiDivision of Hematology, Department of Hematology and Medical Oncology, the Winship Cancer Institute at Emory University, Atlanta, Georgia, USA
&
Hanna Jean KhouryDivision of Hematology, Department of Hematology and Medical Oncology, the Winship Cancer Institute at Emory University, Atlanta, Georgia, USACorrespondence[email protected]
Pages 57-62 | Published online: 05 Aug 2013

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kendra Sweet, Javier Pinilla-Ibarz & Ling Zhang. (2014) Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerations. Patient Preference and Adherence 8, pages 981-986.
Read now
Rudolf P Wüthrich & Changlin Mei. (2014) Pharmacological management of polycystic kidney disease. Expert Opinion on Pharmacotherapy 15:8, pages 1085-1095.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.